|
1
|
Tew WP: Ovarian cancer in the older woman.
J Geriatr Oncol. 7:354–361. 2016. View Article : Google Scholar
|
|
2
|
Webb PM and Jordan SJ: Epidemiology of
epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol.
41:3–14. 2017. View Article : Google Scholar
|
|
3
|
Dong X, Men X, Zhang W and Lei P: Advances
in tumor markers of ovarian cancer for early diagnosis. Indian J
Cancer. 51 (Suppl 3):e72–e76. 2014. View Article : Google Scholar
|
|
4
|
Ting DT, Lipson D, Paul S, Brannigan BW,
Akhavanfard S, Coffman EJ, Contino G, Deshpande V, Iafrate AJ,
Letovsky S, et al: Aberrant overexpression of satellite repeats in
pancreatic and other epithelial cancers. Science. 331:593–596.
2011. View Article : Google Scholar
|
|
5
|
Qiu JJ, Lin YY, Ding JX, Feng WW, Jin HY
and Hua KQ: Long non-coding RNA ANRIL predicts poor prognosis and
promotes invasion/metastasis in serous ovarian cancer. Int J Oncol.
46:2497–2505. 2015. View Article : Google Scholar
|
|
6
|
Lai XJ and Cheng HF: lncRNA colon
cancer-associated transcript 1 (CCAT1) promotes proliferation and
metastasis of ovarian cancer via miR-1290. Eur Rev Med Pharmacol
Sci. 22:322–328. 2018.
|
|
7
|
Liu SP, Yang JX, Cao DY and Shen K:
Identification of differentially expressed long non-coding RNAs in
human ovarian cancer cells with different metastatic potentials.
Cancer Biol Med. 10:138–141. 2013.
|
|
8
|
Nikpayam E, Tasharrofi B, Sarrafzadeh S
and Ghafouri-Fard S: The role of long non-coding RNAs in ovarian
cancer. Iran Biomed J. 21:3–15. 2017. View Article : Google Scholar
|
|
9
|
Soudyab M, Iranpour M and Ghafouri-Fard S:
The role of long non-coding RNAs in breast cancer. Arch Iran Med.
19:508–517. 2016.
|
|
10
|
Cech TR and Steitz JA: The noncoding RNA
revolution-trashing old rules to forge new ones. Cell. 157:77–94.
2014. View Article : Google Scholar
|
|
11
|
Bunch H: Gene regulation of mammalian long
non-coding RNA. Mol Genet Genomics. 293:1–15. 2018. View Article : Google Scholar
|
|
12
|
Zhou HL, Luo G, Wise JA and Lou H:
Regulation of alternative splicing by local histone modifications:
Potential roles for RNA-guided mechanisms. Nucleic Acids Res.
42:701–713. 2014. View Article : Google Scholar
|
|
13
|
Yang L, Kirby JE, Sunwoo H and Lee JT:
Female mice lacking Xist RNA show partial dosage compensation and
survive to term. Genes Dev. 30:1747–1760. 2016. View Article : Google Scholar
|
|
14
|
Kanduri C: Long noncoding RNAs: Lessons
from genomic imprinting. Biochim Biophys Acta. 1859:102–111. 2016.
View Article : Google Scholar
|
|
15
|
Malakootian M, Mirzadeh Azad F, Fouani Y,
Taheri Bajgan E, Saberi H and Mowla SJ: Anti-differentiation
non-coding RNA, ANCR, is differentially expressed in different
types of brain tumors. J Neurooncol. 138:261–270. 2018. View Article : Google Scholar
|
|
16
|
Ranzani V, Arrigoni A, Rossetti G, Panzeri
I, Abrignani S, Bonnal RJP and Pagani M: Next-generation sequencing
analysis of long noncoding RNAs in CD4+ T cell differentiation.
Methods Mol Biol. 1514:173–185. 2017. View Article : Google Scholar
|
|
17
|
Dong J, Xu J, Wang X and Jin B: Influence
of the interaction between long noncoding RNAs and hypoxia on
tumorigenesis. Tumour Biol. 37:1379–1385. 2016. View Article : Google Scholar
|
|
18
|
Lou Y, Jiang H, Cui Z, Wang L, Wang X and
Tian T: Linc-ROR induces epithelial-to-mesenchymal transition in
ovarian cancer by increasing Wnt/β-catenin signaling. Oncotarget.
8:69983–69994. 2017. View Article : Google Scholar
|
|
19
|
Zheng ZG, Xu H, Suo SS, Xu XL, Ni MW, Gu
LH, Chen W, Wang LY, Zhao Y, Tian B and Hua YJ: The essential role
of H19 contributing to cisplatin resistance by regulating
glutathione metabolism in high-grade serous ovarian cancer. Sci
Rep. 6:260932016. View Article : Google Scholar
|
|
20
|
Gao C, Zhao D, Zhao Q, Dong D, Mu L, Zhao
X, Guo M, Xu A, Fang L, Liu Q and Che J: Microarray profiling and
co-expression network analysis of lncRNAs and mRNAs in ovarian
cancer. Cell Death Discov. 5:932019. View Article : Google Scholar
|
|
21
|
Zhang B, Li C and Sun Z: Long non-coding
RNA LINC00346, LINC00578, LINC00673, LINC00671, LINC00261, and
SNHG9 are novel prognostic markers for pancreatic cancer. Am J
Transl Res. 10:2648–2658. 2018.
|
|
22
|
Yu Y, Li Y, Zhou L, Yang G, Wang M and
Hong Y: Cryptochrome 2 (CRY2) suppresses proliferation and
migration and regulates clock gene network in osteosarcoma cells.
Med Sci Monit. 24:3856–3862. 2018. View Article : Google Scholar
|
|
23
|
Fang L, Yang Z, Zhou J, Tung JY, Hsiao CD,
Wang L, Deng Y, Wang P, Wang J and Lee MH: Circadian clock gene
CRY2 degradation is involved in chemoresistance of colorectal
cancer. Mol Cancer Ther. 14:1476–1487. 2015. View Article : Google Scholar
|
|
24
|
Tokunaga H, Takebayashi Y, Utsunomiya H,
Akahira JI, Higashimoto M, Mashiko M, Ito K, Niikura H, Takenoshita
SI and Yaegashi N: Clinicopathological significance of circadian
rhythm-related gene expression levels in patients with epithelial
ovarian cancer. Acta Obstet Gynecol Scand. 87:1060–1070. 2008.
View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
Helder-Woolderink JM, Blok EA, Vasen HF,
Hollema H, Mourits MJ and De Bock GH: Ovarian cancer in Lynch
syndrome; a systematic review. Eur J Cancer. 55:65–73. 2016.
View Article : Google Scholar
|
|
27
|
Miao H, Wang L, Zhan H, Dai J, Chang Y, Wu
F, Liu T, Liu Z, Gao C, Li L and Song X: A long noncoding RNA
distributed in both nucleus and cytoplasm operates in the
PYCARD-regulated apoptosis by coordinating the epigenetic and
translational regulation. PLoS Genet. 15:e10081442019. View Article : Google Scholar
|
|
28
|
Liu L, Shen H and Wang Y: CRY2 is
suppressed by FOXM1 mediated promoter hypermethylation in breast
cancer. Biochem Biophys Res Commun. 490:44–50. 2017. View Article : Google Scholar
|
|
29
|
Li P, Tong L, Song Y, Sun J, Shi J, Wu Z,
Diao Y, Li Y and Wang Z: Long noncoding RNA H19 participates in
metformin-mediated inhibition of gastric cancer cell invasion. J
Cell Physiol. 234:4515–4527. 2019. View Article : Google Scholar
|
|
30
|
Yao P, Ni Y and Liu C: Long non-coding RNA
691 regulated PTEN/PI3K/AKT signaling pathway in osteosarcoma
through miRNA-9-5p. Onco Targets Ther. 13:4597–4606. 2020.
View Article : Google Scholar
|
|
31
|
Yu F, Zhou G, Huang K, Fan X, Li G, Chen
B, Dong P and Zheng J: Serum lincRNA-p21 as a potential biomarker
of liver fibrosis in chronic hepatitis B patients. J Viral Hepat.
24:580–588. 2017. View Article : Google Scholar
|
|
32
|
Birgani MT, Hajjari M, Shahrisa A,
Khoshnevisan A, Shoja Z, Motahari P and Farhangi B: Long non-coding
RNA SNHG6 as a potential biomarker for hepatocellular carcinoma.
Pathol Oncol Res. 24:329–337. 2018. View Article : Google Scholar
|
|
33
|
Fu LL, Li CJ, Xu Y, Li LY, Zhou X, Li DD,
Chen SX, Wang FG, Zhang XY and Zheng LW: Role of lncRNAs as novel
biomarkers and therapeutic targets in ovarian cancer. Crit Rev
Eukaryot Gene Expr. 27:183–195. 2017. View Article : Google Scholar
|
|
34
|
Zhao L, Ji G, Le X, Wang C, Xu L, Feng M,
Zhang Y, Yang H, Xuan Y, Yang Y, et al: Long noncoding RNA
LINC00092 acts in cancer-associated fibroblasts to drive glycolysis
and progression of ovarian cancer. Cancer Res. 77:1369–1382. 2017.
View Article : Google Scholar
|
|
35
|
Zhang LQ, Yang SQ, Wang Y, Fang Q, Chen
XJ, Lu HS and Zhao LP: Long noncoding RNA MIR4697HG promotes cell
growth and metastasis in human ovarian cancer. Anal Cell Pathol
(Amst). 2017:82678632017.
|
